Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Poskus

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|January 9, 2026
Hydrogel array patterning using 3D-printed microfluidic inserts to control cell-cell and cell-ECM interactionsMatthew D Poskus, Mohammadmahdi Eskandarisani, Ioannis K Zervantonakis
Trends in Cancer|August 9, 2023
Beyond matrix stiffness: targeting force-induced cancer drug resistanceMaria Kalli, Matthew D Poskus, Triantafyllos Stylianopoulos, et al.
Micromachines|June 27, 2024
Empirical and Computational Evaluation of Hemolysis in a Microfluidic Extracorporeal Membrane Oxygenator PrototypeNayeem Imtiaz, Matthew D Poskus, William A Stoddard, et al.
Microsystems & Nanoengineering|November 13, 2023
Fabrication of 3D-printed molds for polydimethylsiloxane-based microfluidic devices using a liquid crystal display-based vat photopolymerization process: printing quality, drug response and 3D invasion cell culture assaysMatthew D Poskus, Tuo Wang, Yuxuan Deng, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cellsMatthew D Poskus, Jacob McDonald, Matthew Laird, et al.
Cellular and Molecular Bioengineering|November 8, 2024
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer CellsMatthew D Poskus, Jacob McDonald, Matthew Laird, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathwaysIoannis K Zervantonakis, Matthew D Poskus, Alexis L Scott, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|January 9, 2026
Hydrogel array patterning using 3D-printed microfluidic inserts to control cell-cell and cell-ECM interactionsMatthew D Poskus, Mohammadmahdi Eskandarisani, Ioannis K Zervantonakis
Trends in Cancer|August 9, 2023
Beyond matrix stiffness: targeting force-induced cancer drug resistanceMaria Kalli, Matthew D Poskus, Triantafyllos Stylianopoulos, et al.
Micromachines|June 27, 2024
Empirical and Computational Evaluation of Hemolysis in a Microfluidic Extracorporeal Membrane Oxygenator PrototypeNayeem Imtiaz, Matthew D Poskus, William A Stoddard, et al.
Microsystems & Nanoengineering|November 13, 2023
Fabrication of 3D-printed molds for polydimethylsiloxane-based microfluidic devices using a liquid crystal display-based vat photopolymerization process: printing quality, drug response and 3D invasion cell culture assaysMatthew D Poskus, Tuo Wang, Yuxuan Deng, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cellsMatthew D Poskus, Jacob McDonald, Matthew Laird, et al.
Cellular and Molecular Bioengineering|November 8, 2024
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer CellsMatthew D Poskus, Jacob McDonald, Matthew Laird, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathwaysIoannis K Zervantonakis, Matthew D Poskus, Alexis L Scott, et al.
Pageof 1